Blood test may forecast lung cancer return after surgery
NCT ID NCT07186855
First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This completed study looked at 500 non-small cell lung cancer patients who had surgery. Researchers collected blood samples before and after surgery to detect circulating tumor cells (CTCs). They then analyzed these cells to see if their presence could predict cancer recurrence or survival. The goal is to improve follow-up care by identifying high-risk patients earlier.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this monitoring approach could help doctors better predict which lung cancer patients are at higher risk of recurrence after surgery.
- What could go wrong
- This is an observational study, not a treatment trial. The results may not lead to immediate changes in patient care, and the technology may not prove reliable enough for routine use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER (NSCLC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nationa Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Beijing, Beijingn, 100021, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Microwave ablation vs. radiotherapy: which Non-Surgical option works best for early lung cancer?
- Double-Targeted therapy aims to outsmart Hard-to-Treat lung cancer
- New radiation technique aims to shield airways and preserve lung function
- AI assistant could help junior doctors plan lung cancer surgeries
- New drug cocktail targets Hard-to-Treat lung cancer
- App-Based breathing training aims to boost lung cancer recovery